Pink Sheet - News And Expert Analysis On Pharma Policy And Regulation since 1939

The Indian government is reported to be considering curbs like the Essential Commodities Act - last put to use during COVID – for pharma amid the ongoing war between the US-Israel coalition and Iran. What is prompting the move and what does industry have to say?

Policy experts assess the viability of exemptions from the Medicare Most Favored Nation payment demonstrations that companies that have sealed voluntary MFN deals with the Administration believe they are entitled to.

Participants in the qualification process for BMD in osteoporosis are optimistic future uses of the US FDA pathway will be less time consuming, but staff resources still are a major challenge for the agency.

The health technology assessment institute, NICE, has recommended making Novo Nordisk’s drug available via England’s National Health Service for more than a million people to help reduce the risk of major adverse cardiovascular events.

The Germany-based family-owned company, which has posted a decent set of financials for 2025 driven by Jardiance and Ofev, is particularly concerned about the red tape involved in getting clinical trials off the ground.

Country still trying to encourage shots after nationwide probe into post symptoms led to a long halt, but rates remain low.